The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer

Pancreatic ductal adenocarcinoma (PDA) is associated with an immunosuppressive tumor‐microenvironment (TME) that supports the growth of tumors and mediates tumors enabling evasion of the immune system. Expression of programmed cell death ligand 1 (PD‐L1) and loss of human leukocyte antigen (HLA) cla...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Med
Autors principals: Imai, Daisuke, Yoshizumi, Tomoharu, Okano, Shinji, Uchiyama, Hideaki, Ikegami, Toru, Harimoto, Norifumi, Itoh, Shinji, Soejima, Yuji, Aishima, Shinichi, Oda, Yoshinao, Maehara, Yoshihiko
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Clinical Cancer Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5504334/
https://ncbi.nlm.nih.gov/pubmed/28602029
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1087
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars